Schedule 13G ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2024-03-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,223,994
- Percent of class
- 10.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-24-000015
- Form type
- SC 13G
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Apr 10, 2024
- Reporting period
- Mar 29, 2024
- Description
- Schedule 13G beneficial ownership